Ifigenia Tzannou

553 total citations
7 papers, 422 citations indexed

About

Ifigenia Tzannou is a scholar working on Oncology, Epidemiology and Genetics. According to data from OpenAlex, Ifigenia Tzannou has authored 7 papers receiving a total of 422 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 5 papers in Epidemiology and 3 papers in Genetics. Recurrent topics in Ifigenia Tzannou's work include Virus-based gene therapy research (3 papers), Cytomegalovirus and herpesvirus research (3 papers) and Radiomics and Machine Learning in Medical Imaging (1 paper). Ifigenia Tzannou is often cited by papers focused on Virus-based gene therapy research (3 papers), Cytomegalovirus and herpesvirus research (3 papers) and Radiomics and Machine Learning in Medical Imaging (1 paper). Ifigenia Tzannou collaborates with scholars based in United States and Greece. Ifigenia Tzannou's co-authors include Kostas Syrigos, Muhammad Wasif Saif, Nektaria Makrilia, Malcolm K. Brenner, Ulrike Gerdemann, Juan F. Vera, Ann M. Leen, George Carrum, Kathryn Leung and Adrian P. Gee and has published in prestigious journals such as Science Translational Medicine, Biology of Blood and Marrow Transplantation and Medical Oncology.

In The Last Decade

Ifigenia Tzannou

7 papers receiving 417 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ifigenia Tzannou United States	5	246	187	97	82	66	7	422
AL Zignego Italy	7	94 0.4×	440 2.4×	46 0.5×	111 1.4×	45 0.7×	7	794
Haili Lang United States	11	161 0.7×	97 0.5×	85 0.9×	166 2.0×	69 1.0×	37	383
Kenyetta R. McDonald United States	9	84 0.3×	95 0.5×	36 0.4×	133 1.6×	47 0.7×	9	322
Jane Burgess Australia	14	239 1.0×	344 1.8×	210 2.2×	162 2.0×	83 1.3×	21	670
Grażyna Kamińska‐Winciorek Poland	10	214 0.9×	146 0.8×	42 0.4×	49 0.6×	14 0.2×	89	418
T Matsuyama Japan	17	223 0.9×	198 1.1×	85 0.9×	86 1.0×	74 1.1×	33	686
Larry J. Fowler United States	12	118 0.5×	105 0.6×	37 0.4×	33 0.4×	85 1.3×	24	465
Andrea Siegel United States	11	167 0.7×	113 0.6×	54 0.6×	329 4.0×	31 0.5×	15	523
Elke Dammann Germany	16	161 0.7×	204 1.1×	65 0.7×	100 1.2×	39 0.6×	36	555
Federico Serana Italy	16	145 0.6×	115 0.6×	93 1.0×	376 4.6×	50 0.8×	41	576

Countries citing papers authored by Ifigenia Tzannou

Since Specialization

Citations

This map shows the geographic impact of Ifigenia Tzannou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ifigenia Tzannou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ifigenia Tzannou more than expected).

Fields of papers citing papers by Ifigenia Tzannou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ifigenia Tzannou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ifigenia Tzannou. The network helps show where Ifigenia Tzannou may publish in the future.

Co-authorship network of co-authors of Ifigenia Tzannou

This figure shows the co-authorship network connecting the top 25 collaborators of Ifigenia Tzannou. A scholar is included among the top collaborators of Ifigenia Tzannou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ifigenia Tzannou. Ifigenia Tzannou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Tzannou, Ifigenia, Sarah K. Nicholas, Usha L. Katari, et al.. (2015). Adoptive T-Cell Therapy to Prevent and Treat Human Metapneumovirus (hMPV) Infections Post Hematopoietic Stem Cell Transplant (HSCT). Biology of Blood and Marrow Transplantation. 21(2). S170–S170. 2 indexed citations

2.

Παπαδοπούλου, Αναστασία, Ulrike Gerdemann, Usha L. Katari, et al.. (2014). Activity of Broad-Spectrum T Cells as Treatment for AdV, EBV, CMV, BKV, and HHV6 Infections after HSCT. Science Translational Medicine. 6(242). 242ra83–242ra83. 298 indexed citations

3.

Παπαδοπούλου, Αναστασία, Usha L. Katari, Ulrike Gerdemann, et al.. (2014). Safety and Clinical Efficacy of Rapidly-Generated Virus-Specific T Cells with Activity Against Adv, EBV, CMV, HHV6 and BK Virus Administered after Allogeneic Hematopoietic Stem Cell Transplant. Biology of Blood and Marrow Transplantation. 20(2). S48–S48. 2 indexed citations

4.

Saif, Muhammad Wasif, Ifigenia Tzannou, Nektaria Makrilia, & Kostas Syrigos. (2010). Role and cost effectiveness of PET/CT in management of patients with cancer.. PubMed. 83(2). 53–65. 87 indexed citations

5.

Karapanagiotou, Eleni, et al.. (2008). A phase II study of sequential docetaxel and gemcitabine followed by docetaxel and carboplatin as first-line therapy for non-small cell lung cancer. Medical Oncology. 25(3). 303–308. 4 indexed citations

6.

Saif, Muhammad Wasif, et al.. (2006). Metastatic cervical carcinoma to the thyroid gland: a case report and review of the literature.. PubMed. 79(3-4). 165–8. 14 indexed citations

7.

Syrigos, Konstantinos N., et al.. (2005). Skin cancer in the elderly.. PubMed. 19(3). 643–52. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact